The Longevity Clinics Are Moving to Arizona. Here Is What They Are Selling.

Comprehensive longevity programs typically begin with advanced cardiovascular biomarker panels that go beyond the standard lipid panel. Apolipoprotein B, which measures the number of atherogenic particles in the blood, is more predictive of cardiovascular risk than LDL cholesterol and is rarely included in routine bloodwork. Lipoprotein(a), a genetically determined cardiovascular risk factor that affects roughly 20 percent of the population, is almost never measured in standard care.

Fasting insulin, HOMA-IR for insulin resistance assessment, high-sensitivity CRP for inflammation, and comprehensive metabolic markers form the baseline. More advanced programs add uric acid, homocysteine, and full thyroid panels including reverse T3. The goal is not to identify disease but to identify trajectories before they produce symptoms.

Coronary artery calcium scoring uses a CT scan to quantify calcified plaque in the coronary arteries. It is one of the most powerful predictors of future cardiac events available and costs roughly $200 to $400 out of pocket. Longevity clinics in Scottsdale routinely order this test for patients over 40. Most primary care offices do not.

Carotid intima media thickness testing uses ultrasound to measure the wall thickness of the carotid arteries, providing an earlier signal of atherosclerosis than calcium scoring in younger patients. Advanced programs also include cardiac MRI for patients with elevated risk scores, providing detailed myocardial function data that echocardiography misses.

VO2 max, the maximum rate of oxygen consumption during exercise, is one of the strongest predictors of all-cause mortality in large epidemiological datasets. It is also trainable. Longevity clinics that include exercise physiology testing conduct formal VO2 max assessments and use the results to design zone 2 training protocols, aerobic work done at intensities where fat oxidation is primary and lactate remains below threshold.

Continuous glucose monitors, worn for two to four weeks, provide detailed pictures of metabolic responses to food, sleep quality, and stress. The CGM findings often reveal significant glucose variability in patients who have normal fasting glucose and HbA1c, suggesting early insulin resistance that standard testing would miss.

Diagnostic rigor is one thing. The therapeutic interventions offered at many longevity clinics occupy a more complicated evidentiary landscape. NAD+ infusions are based on promising preclinical research and mechanistic rationale but lack large randomized controlled trials demonstrating clinical benefit in healthy humans. Peptide therapies, including BPC-157 and various growth hormone secretagogues, are largely studied in animal models.

Hormone optimization programs, including testosterone replacement in men and hormone therapy in post-menopausal women, have a better evidence base, though optimal protocols and long-term risk profiles remain actively debated in the medical literature. The gap between the diagnostic quality and the therapeutic evidence quality at many clinics is something prospective patients should ask about directly.

The most important questions for evaluating a Scottsdale longevity clinic are: What is the medical director's training and board certification? How does the clinic handle findings that require specialist referral? What is the evidence basis for each recommended intervention, and what does the clinic consider the relevant literature? A clinic that answers these questions with specificity and intellectual honesty is worth taking seriously. One that deflects toward testimonials and brand language is not.